Company: STAA
Filing Date: 2025-12-10
Form Type: DEFA14A
Source: 0001193125-25-314435
Chunk: 6

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DEFA14A
Chunk 6
---
.75 per share in cash, without interest, subject to any applicable withholding taxes. |

In addition, the Second Amendment (i) provides that each STAAR RSU Award that was awarded prior to August 4, 2025 or that is held by a director, and each STAAR PSU Award, will be converted into a restricted stock unit award of Alcon Inc. in respect of a number of ordinary shares, nominal value CHF 0.04 per share, of Alcon Inc. (“Alcon shares”) calculated based on the value of the Merger Consideration relative to the trading price of Alcon shares prior to the closing of the Merger, with STAAR PSU Award performance deemed to be earned at 100% of target, and otherwise generally subject to the same terms and conditions (except that (A) director Adjusted RSU Awards (as defined below) will become vested at the closing and (B) 50% of the Adjusted PSU Awards (as defined below) will become vested on the 15th day of the second month following the quarter in which the Closing Date occurs and, without limiting any “double-trigger” vesting protections, the remaining 50% of the Adjusted PSU Awards will become vested on (subject to continued service through) the first anniversary of the vesting date for the first 50%); and (ii) eliminates STAAR’s ability to pay any 280G gross-ups and enter into any related tax indemnification arrangements in connection with the Merger. 5

The Board approved the Second Amendment after careful consideration and deliberation and determined that the Merger Agreement and the transactions contemplated thereby, as amended by the Amendments, including the Merger, are advisable, fair to and in the best interests of STAAR and its stockholders, approved, adopted and declared advisable the execution and delivery of, and entry into, the Second Amendment, and directed that the Merger Agreement be submitted to the STAAR stockholders for adoption at the Special Meeting. The following questions and answers on page 13 of the proxy supplement are hereby amended and supplemented as follows:

| Q: | How does the Merger Consideration compare to the market price of STAAR common stock prior to the 
 announcement of the Merger Agreement?                                                            |

| A: | The Merger Consideration of $28.00 $30.75 per share represents a premium of                                                                                                                                                                  
 approximately 59% 74% to the 90-day volume weighted average price of STAAR common stock at the